Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?Peter L. Havens, Kathleen Mulligan, Brandy Rutledge et al.|Antimicrobial Agents and Chemotherapy|2013Cited by 63
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure ProphylaxisPeter L. Havens, Charles B. Stephensen, Marta D. Van Loan et al.|Clinical Infectious Diseases|2016Cited by 51
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled TrialPeter L. Havens, Angulique Y. Outlaw, Charles B. Stephensen et al.|Clinical Infectious Diseases|2017Cited by 44
Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil FumaratePeter L. Havens, Rohan Hazra, Charles B. Stephensen et al.|Antiviral Therapy|2013Cited by 13